Cargando…

Time above range for predicting the development of type 2 diabetes

AIM: To investigate the prognostic value of time range metrics, as measured by continuous glucose monitoring, with respect to the development of type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: A total of 499 persons without diabetes from the general population were followed-up for 5 years. Time...

Descripción completa

Detalles Bibliográficos
Autores principales: Marco, Alejandra, Pazos-Couselo, Marcos, Moreno-Fernandez, Jesús, Díez-Fernández, Ana, Alonso-Sampedro, Manuela, Fernández-Merino, Carmen, Gonzalez-Quintela, Arturo, Gude, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772988/
https://www.ncbi.nlm.nih.gov/pubmed/36568777
http://dx.doi.org/10.3389/fpubh.2022.1005513
_version_ 1784855100985966592
author Marco, Alejandra
Pazos-Couselo, Marcos
Moreno-Fernandez, Jesús
Díez-Fernández, Ana
Alonso-Sampedro, Manuela
Fernández-Merino, Carmen
Gonzalez-Quintela, Arturo
Gude, Francisco
author_facet Marco, Alejandra
Pazos-Couselo, Marcos
Moreno-Fernandez, Jesús
Díez-Fernández, Ana
Alonso-Sampedro, Manuela
Fernández-Merino, Carmen
Gonzalez-Quintela, Arturo
Gude, Francisco
author_sort Marco, Alejandra
collection PubMed
description AIM: To investigate the prognostic value of time range metrics, as measured by continuous glucose monitoring, with respect to the development of type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: A total of 499 persons without diabetes from the general population were followed-up for 5 years. Time range metrics were measured at the start and medical records were checked over the period study. RESULTS: Twenty-two subjects (8.3 per 1,000 person-years) developed T2D. After adjusting for age, gender, family history of diabetes, body mass index and glycated hemoglobin concentration, multivariate analysis revealed 'time above range' (TAR, i.e., with a plasma glucose concentration of >140 mg/dL) to be significantly associated with a greater risk (OR = 1.06, CI 1.01–1.11) of developing diabetes (AUC = 0.94, Brier = 0.035). CONCLUSIONS: Time above range provides additional information to that offered by glycated hemoglobin to identify patients at a higher risk of developing type 2 diabetes in a population-based study.
format Online
Article
Text
id pubmed-9772988
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97729882022-12-23 Time above range for predicting the development of type 2 diabetes Marco, Alejandra Pazos-Couselo, Marcos Moreno-Fernandez, Jesús Díez-Fernández, Ana Alonso-Sampedro, Manuela Fernández-Merino, Carmen Gonzalez-Quintela, Arturo Gude, Francisco Front Public Health Public Health AIM: To investigate the prognostic value of time range metrics, as measured by continuous glucose monitoring, with respect to the development of type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: A total of 499 persons without diabetes from the general population were followed-up for 5 years. Time range metrics were measured at the start and medical records were checked over the period study. RESULTS: Twenty-two subjects (8.3 per 1,000 person-years) developed T2D. After adjusting for age, gender, family history of diabetes, body mass index and glycated hemoglobin concentration, multivariate analysis revealed 'time above range' (TAR, i.e., with a plasma glucose concentration of >140 mg/dL) to be significantly associated with a greater risk (OR = 1.06, CI 1.01–1.11) of developing diabetes (AUC = 0.94, Brier = 0.035). CONCLUSIONS: Time above range provides additional information to that offered by glycated hemoglobin to identify patients at a higher risk of developing type 2 diabetes in a population-based study. Frontiers Media S.A. 2022-12-08 /pmc/articles/PMC9772988/ /pubmed/36568777 http://dx.doi.org/10.3389/fpubh.2022.1005513 Text en Copyright © 2022 Marco, Pazos-Couselo, Moreno-Fernandez, Díez-Fernández, Alonso-Sampedro, Fernández-Merino, Gonzalez-Quintela and Gude. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Marco, Alejandra
Pazos-Couselo, Marcos
Moreno-Fernandez, Jesús
Díez-Fernández, Ana
Alonso-Sampedro, Manuela
Fernández-Merino, Carmen
Gonzalez-Quintela, Arturo
Gude, Francisco
Time above range for predicting the development of type 2 diabetes
title Time above range for predicting the development of type 2 diabetes
title_full Time above range for predicting the development of type 2 diabetes
title_fullStr Time above range for predicting the development of type 2 diabetes
title_full_unstemmed Time above range for predicting the development of type 2 diabetes
title_short Time above range for predicting the development of type 2 diabetes
title_sort time above range for predicting the development of type 2 diabetes
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772988/
https://www.ncbi.nlm.nih.gov/pubmed/36568777
http://dx.doi.org/10.3389/fpubh.2022.1005513
work_keys_str_mv AT marcoalejandra timeaboverangeforpredictingthedevelopmentoftype2diabetes
AT pazoscouselomarcos timeaboverangeforpredictingthedevelopmentoftype2diabetes
AT morenofernandezjesus timeaboverangeforpredictingthedevelopmentoftype2diabetes
AT diezfernandezana timeaboverangeforpredictingthedevelopmentoftype2diabetes
AT alonsosampedromanuela timeaboverangeforpredictingthedevelopmentoftype2diabetes
AT fernandezmerinocarmen timeaboverangeforpredictingthedevelopmentoftype2diabetes
AT gonzalezquintelaarturo timeaboverangeforpredictingthedevelopmentoftype2diabetes
AT gudefrancisco timeaboverangeforpredictingthedevelopmentoftype2diabetes